ZARS Pharma Inc.

Quick facts

Phase 3 pipeline

• Ketoprofen matrix/placebo CHADD Patch · Pain Management / Rheumatology
  Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain.
• Placebo Matrix/CHADD Patch
  The Placebo Matrix/CHADD Patch does not contain an active pharmaceutical ingredient and is used as a control in clinical trials.
• Placebo Peel
  Placebo Peel does not have a known mechanism of action.

Phase 2 pipeline

• Heated Lidocaine and Tetracaine Patch
• Transdermal Ketoprofen Patch with CHADD

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• ZARS Pharma Inc. portfolio CI brief
• ZARS Pharma Inc. pipeline updates RSS